Should a patient with diabetes, prior abdominal surgery, and metabolic acidosis, on Invokana (canagliflozin), with worsening laboratory results after chloride-rich fluids, undergo immediate surgery or be stabilized first?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Surgery Must Be Delayed for Metabolic Stabilization

This patient has euglycemic diabetic ketoacidosis (DKA) from canagliflozin with worsening metabolic acidosis (pH 7.24 dropping after chloride-rich fluids), and proceeding to surgery now would be catastrophic—immediate stabilization with insulin infusion, balanced crystalloids, and bicarbonate therapy is mandatory before any elective procedure. 1, 2

Critical Problem: SGLT2 Inhibitor-Induced Euglycemic DKA

  • Canagliflozin causes euglycemic DKA, defined as pH <7.3, bicarbonate <18 mEq/L (patient has 17, now 13), and elevated ketones despite normal glucose—this patient's 5-day history of poor oral intake, nausea, and abdominal pain are classic triggers. 1, 3

  • The metabolic acidosis is worsening (bicarbonate dropped from 17 to 13 after chloride-rich fluids), with pH 7.24, base excess -9, and anion gap 15—this represents ongoing ketoacidosis that will deteriorate further under surgical stress. 2, 3, 4

  • Canagliflozin should have been stopped 3-4 days before any planned surgery to prevent this exact complication, but the patient is now presenting with established DKA requiring urgent medical management before surgical intervention. 1

Why Surgery Cannot Proceed Now

  • Metabolic acidosis with pH <7.2 or base deficit >8 represents the "lethal triad" (acidosis, hypothermia, coagulopathy) that mandates abbreviated surgery or delay—this patient has pH 7.24 with BE -9, approaching these critical thresholds. 2, 5

  • Induction of anesthesia in an acidotic, volume-depleted patient causes hemodynamic collapse due to loss of compensatory mechanisms and catecholamine receptor resistance—the patient needs resuscitation first to prevent cardiovascular arrest on induction. 1, 2

  • The chloride-rich fluids worsened the acidosis (hyperchloremic metabolic acidosis), demonstrating improper resuscitation strategy—switching to balanced crystalloids is essential before proceeding. 2, 6

Immediate Stabilization Protocol

Stop the Offending Agent

  • Discontinue canagliflozin immediately (should have been stopped 3-4 days pre-surgery)—note that glucosuria can persist for >10 days after stopping SGLT2 inhibitors, requiring ongoing monitoring. 1, 7

Correct the Ketoacidosis

  • Start continuous insulin infusion (5-10 units/hour) with dextrose-containing fluids once glucose normalizes to suppress ketogenesis—this is the definitive treatment for euglycemic DKA. 3, 4, 8

  • Administer sodium bicarbonate for pH <7.15—while not routinely recommended for lactic acidosis, bicarbonate is indicated when pH drops below 7.15 due to catecholamine receptor resistance causing refractory hypotension. 1, 2

  • Check beta-hydroxybutyrate levels to confirm ketoacidosis and monitor response to therapy—levels should decrease with insulin therapy. 3, 4, 7

Optimize Fluid Resuscitation

  • Switch immediately to balanced crystalloids (lactated Ringer's or Plasma-Lyte)—normal saline contains supraphysiological chloride that worsens hyperchloremic acidosis and impairs renal/gastric perfusion. 2, 6

  • Target MAP ≥65 mmHg, CVP 8-12 mmHg, and ScvO2 ≥70% within 6 hours—failure to achieve these goals within 6 hours in abdominal pathology with septic shock results in 0% survival. 1, 2

  • Monitor lactate clearance (current lactate 1.3 is reassuring but needs serial monitoring)—persistent or rising lactate despite resuscitation suggests ongoing tissue hypoperfusion or unrecognized pathology. 2

Address Electrolyte Abnormalities

  • Monitor and replace potassium aggressively—DKA causes total body potassium depletion despite normal serum levels, and insulin therapy will drive potassium intracellularly causing dangerous hypokalemia. 2, 3

  • Check renal function closely (current creatinine 53 μmol/L, eGFR 112 is acceptable)—metformin should have been stopped preoperatively and cannot be restarted until 48 hours post-surgery with confirmed eGFR ≥60. 1, 6

Timeline for Surgery

  • Delay surgery for 24-48 hours minimum until pH >7.30, bicarbonate >18 mEq/L, anion gap normalizes, and ketones clear—attempting surgery before metabolic normalization risks intraoperative cardiovascular collapse. 2, 3, 8

  • Serial arterial blood gases every 2-4 hours to document improvement—if acidosis worsens despite aggressive therapy, consider undiagnosed surgical pathology (bowel ischemia, perforation) requiring damage control approach. 2, 5

  • If this is truly emergent surgery (perforation, ischemic bowel), then proceed with damage control principles: abbreviated laparotomy for source control only, temporary abdominal closure, ICU resuscitation, and return for definitive repair after physiologic normalization. 1, 2, 5

Common Pitfalls to Avoid

  • Do not use normal saline for resuscitation—this patient's bicarbonate dropped from 17 to 13 after chloride-rich fluids, demonstrating iatrogenic worsening of acidosis. 2, 6

  • Do not assume normal glucose excludes DKA—euglycemic DKA is the hallmark complication of SGLT2 inhibitors and requires high clinical suspicion in patients with acidosis and poor oral intake. 1, 3, 4

  • Do not restart canagliflozin postoperatively—SGLT2 inhibitors should not be restarted until the patient is clinically stable, eating normally, and all metabolic derangements have resolved. 1

  • Do not delay surgical intervention if peritonitis or bowel ischemia is confirmed—in that scenario, surgical source control takes priority over complete metabolic correction, using damage control principles. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Intraoperative Metabolic Acidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Metformin in Abdominal Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.

International journal of emergency medicine, 2020

Related Questions

What went wrong in the management of a female patient with a history of type 2 diabetes, Postural Orthostatic Tachycardia Syndrome (POTS), chronic fatigue syndrome, depression, fibromyalgia, Irritable Bowel Syndrome (IBS), migraine, and Gastroesophageal Reflux Disease (GERD), who presented with abdominal pain, nausea, fever, and was diagnosed with early acute appendicitis, and developed severe metabolic acidosis with diabetic ketoacidosis (DKA) post-operatively while on medications including Canagliflozin (SGLT2 inhibitor) and Linagliptin (Dipeptidyl Peptidase-4 inhibitor)?
How do I report a case to the college of physicians and surgeons where a patient with diabetes, taking Invokana (canagliflozin), was not informed of the increased risk of diabetic ketoacidosis (DKA) during surgery with NPO (nil per os) status?
Can a patient with diabetes, taking Invokana (canagliflozin), who presented with abdominal pain, nausea, poor oral intake, acid reflux, belching, dizziness, and fatigue, and had lab results showing metabolic acidosis, be considered a victim of medical malpractice in Canada if their appendicitis diagnosis overshadowed their diabetic ketoacidosis (DKA) management, and they underwent surgery after 20+ hours of nil per os (NPO) and were discharged with severe metabolic acidosis?
What is the appropriate management for an adult patient with a history of diabetes, currently presenting with early appendicitis and metabolic acidosis, who was previously on Invokana (canagliflozin)?
What are the next steps for a diabetic patient on Invokana (canagliflozin) with a 5-day history of nausea, stomach pain, dizziness, low oral intake, and fatigue?
Is hyperkalemia considered a significant part of a patient's past medical history?
What is the difference between STEMI (ST-Elevation Myocardial Infarction) and OMI (Occlusion Myocardial Infarction) anterior on an EKG (Electrocardiogram)?
What is the best approach to treat a patient with hypernatremia?
How to manage a pregnant patient with a neurodevelopmental tumor (NTDT) and pulmonary hypertension?
I have bilateral, non-pulsatile tinnitus due to sensory hearing loss, and recently experienced louder tinnitus, head pressure, and facial tension after caffeine withdrawal, what are my management options?
What is the proper administration and dosing of calcium gluconate for a patient with hypocalcemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.